Sort
59,101 grants matching “hypertension”
Role of Skeletal Muscle in Pulmonary Vascular Remodeling
$437,850Yen Chun Charly Lai · Indiana University Indianapolis · R01 · FY2018 · HL
The Role of Osteopontin-OGDHL Axis in HFpEF
$437,820Lina A Shehadeh · University Of Miami School Of Medicine · R01 · FY2020 · HL
AMINO ACIDS IN URINE, DIET &BP: INT'L POPULATION STUDY
$437,817Northwestern University · R01 · FY2000 · HL
IGF::OT::IGF, R&D - VASCULAR INTERVENTION/INNOVATIONS THERAPEUTIC ADVANCES
$437,794Karen Hansen · Ccs Associates, Inc. · N01 · FY2016 · HL
Antiotensin converting enzyme gene expression
$437,669Ganes C. Sen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2011 · HL
Analytical Methods
$437,639John Joseph Gildea · University Of Virginia · P01 · FY2012 · HL
Administrative Core
$437,639Robin A Felder · University Of Virginia · P01 · FY2012 · HL
Effect of early life stress on obesity-induced hypertension in mice
$437,638Analia Loria · University Of Kentucky · R01 · FY2021 · HL
Antiotensin converting enzyme gene expression
$437,633Ganes C. Sen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2012 · HL
Dynamic Interactions of Cardiac Troponin and Tropomyosin
$437,624Larry S Tobacman · University Of Illinois At Chicago · R01 · FY2011 · HL
Randomized trial of active vitamin D, cholecalciferol and placebo for CKD-MBD
$437,593Sharon M Moe · Indiana University Indianapolis · U34 · FY2011 · DK
MOLECULAR BASIS FOR Kv CHANNEL HETEROGENEITY IN THE HEART
$437,573Gea-Ny Tseng · Virginia Commonwealth University · R01 · FY2010 · HL
Molecular Regulation of Cardiovascular 7 TM Receptors
$437,565Robert J Lefkowitz · Duke University · R01 · FY2017 · HL
Retrotrapezoid nucleus and central chemoreception
$437,554Patrice G. Guyenet · University Of Virginia · R01 · FY2018 · HL
Retrotrapezoid nucleus and central chemoreception
$437,554Patrice G. Guyenet · University Of Virginia · R01 · FY2016 · HL
Retrotrapezoid nucleus and central chemoreception
$437,554Patrice G. Guyenet · University Of Virginia · R01 · FY2017 · HL
Retrotrapezoid nucleus and central chemoreception
$437,554Patrice G. Guyenet · University Of Virginia · R01 · FY2015 · HL
Nicotinamide riboside supplementation for treating elevated systolic blood pressure and arterial stiffness in middle-aged and older adults
$437,530Douglas R Seals · University Of Colorado · R01 · FY2023 · AG
LEAD BIOMARKERS AGING AND CHRONIC DISEASE
$437,526Brigham And Women'S Hospital · R01 · FY2001 · ES
Investigating the VZV-induced epigenetic modifications of vascular adventitial fibroblasts that contribute to persistent inflammation and VZV vasculopathy
$437,514Randall J. Cohrs · University Of Colorado Denver · P01 · FY2023 · AG
Biobank phenotyping tools for improved understanding and management of eye diseases and disparities
$437,500Dolly Ann Padovani-Claudio · Vanderbilt University Medical Center · R01 · FY2024 · EY
Determining How Lymphatic Molecules Control Conventional Outflow
$437,500Krishnakumar Kizhatil · Jackson Laboratory · R01 · FY2017 · EY
Aldosteron, Intracellular Leukocyte Magnesium and Inflammation in Diabetes
$437,500Jose R Romero · Brigham And Women'S Hospital · R01 · FY2009 · HL
Aldosteron, Intracellular Leukocyte Magnesium and Inflammation in Diabetes
$437,500Jose R Romero · Brigham And Women'S Hospital · R01 · FY2011 · HL
Biobank phenotyping tools for improved understanding and management of eye diseases and disparities
$437,500Dolly Ann Padovani-Claudio · Vanderbilt University Medical Center · R01 · FY2025 · EY